Oral lipid formulation type IV as an approach in the formulation of solid dosage forms with poorly soluble substances: Chremophor®RH 40 as a surfactant phase. (2021). Progress in Nutrition, 23(3), e2021279. https://doi.org/10.23751/pn.v23i3.12071